A revolutionary antiviral drug
called sofosbuvir is a member of the
DAA (direct-acting antiviral) class of drugs. It offers patients all around the
world a very efficient and well-tolerated therapeutic alternative for the
treatment of chronic hepatitis C virus (HCV) infection. This amazing medication
works by specifically targeting the RNA-dependent RNA polymerase, an enzyme
involved in the reproduction of the HCV virus. Sofosbuvir efficiently interferes with the virus's capacity to
reproduce and propagate throughout the body by blocking this crucial enzyme.
They are appropriate for a variety of individuals, including those with
concomitant illnesses or liver cirrhosis.
Send Inquiry
